{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:27:08Z","timestamp":1777426028551,"version":"3.51.4"},"reference-count":59,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The<jats:italic>Leishmania pifanoi<\/jats:italic>amastigote antigen P-8 has been previously shown to induce protective immunity in a murine model of cutaneous leishmaniasis (L. Soong, S. M. Duboise, P. Kima, and D. McMahon-Pratt, Infect. Immun. 63:3559\u20133566, 1995). As this antigen is of interest for further vaccine studies, the biochemical characterization of P-8 was undertaken. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western-blot analysis, and gel filtration chromatography revealed that P-8 antigen consisted of two proteoglycolipid complexes. The P-8 epitope is associated with the<jats:italic>L. pifanoi<\/jats:italic>amastigote-specific glycolipid components found in the two complexes. The P-8 complex 1 (P-8c1) consists of a 56-kDa serine metalloproteinase, apolipoprotein E (derived from fetal bovine serum), and amastigote-specific glycolipids. The P-8 complex 2 (P-8c2) consists of a 31-kDa cysteine proteinase associated with amastigote glycolipids. Biochemical analyses suggest that the P-8 antigenic glycolipids may be distinct from previously described<jats:italic>Leishmania<\/jats:italic>glycolipids (glycosylinositolphospholipids and sphingoglycolipids). Protective immunity studies revealed that P-8c1 (serine metalloproteinase-glycolipid complex) confers comparable protection against infection as immunopurified P-8. The isolated P-8c2 (cysteine proteinase-glycolipid complex) does not provide significant protection, nor does stimulation with P-8c2 result in significant T-cell activation in P-8- or P-8c2-vaccinated mice. Consequently, the P-8c1 complex appears to be the immunodominant component of P-8.<\/jats:p>","DOI":"10.1128\/iai.69.11.6776-6784.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:59Z","timestamp":1027764239000},"page":"6776-6784","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Biochemical and Biological Characterization of the Protective<i>Leishmania pifanoi<\/i>Amastigote Antigen P-8"],"prefix":"10.1128","volume":"69","author":[{"given":"M.","family":"Colmenares","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Epidemiology and Public Health1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tiemeyer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Cell Biology,2 Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kima","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Epidemiology and Public Health1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McMahon-Pratt","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Epidemiology and Public Health1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(98)01324-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/15.4.572"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(93)90095-F"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(95)00113-F"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1993.1050"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.12.3272-3279.1988"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600110025007"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1984.11811768"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X1998000100019"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1997.4269"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(91)90104-5"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(94)00157-X"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1989.tb01087.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1989.tb01086.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(73)90113-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(90)90201-V"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000079683"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.6.3.230"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(72)90152-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.17.5910"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(88)90089-9"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a122828"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.4049\/jimmunol.129.5.2206","article-title":"Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection","volume":"129","author":"Howard J. G.","year":"1982","unstructured":"Howard J. G. Nicklin S. Hale C. Liew F. Y. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.J. Immunol.129198222062212","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.2.645"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.4049\/jimmunol.142.12.4441","article-title":"Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen\/liposomes. Optimization and assessment of the requirement for intravenous immunization","volume":"142","author":"Kahl L. P.","year":"1989","unstructured":"Kahl L. P. Scott C. A. Lelchuk R. Gregoriadis G. Liew F. Y. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen\/liposomes. Optimization and assessment of the requirement for intravenous immunization.J. Immunol.142198944414449","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830261249"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90667-3"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)98600-X"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)82298-0"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2940305"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.8.3351-3359.1993"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(89)90158-8"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7519(85)90015-3"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.19.14147"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.22.14285"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.7.2198-2203.1990"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.4049\/jimmunol.140.7.2406","article-title":"Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants","volume":"140","author":"Pan A. A.","year":"1988","unstructured":"Pan A. A. McMahon-Pratt D. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.J. Immunol.140198824062414","journal-title":"J. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.2307\/3281780"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1993.1061"},{"key":"e_1_3_2_42_2","first-page":"2375","article-title":"Purification and characterization of proteolytic enzymes of Leishmania mexicana mexicana amastigotes and promastigotes","volume":"130","author":"Pupkis M. F.","year":"1984","unstructured":"Pupkis M. F. Coombs G. H. Purification and characterization of proteolytic enzymes of Leishmania mexicana mexicana amastigotes and promastigotes.J. Gen. Microbiol.130198423752383","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(93)90116-F"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-140-2-417"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0769-2625(87)80037-5"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.140.4.1274","article-title":"Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes","volume":"140","author":"Russell D. G.","year":"1988","unstructured":"Russell D. G. Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.J. Immunol.140198812741279 (Erratum, 140:2858.)","journal-title":"J. Immunol."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.13.4863"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(92)90179-E"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0769-2625(87)80036-3"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott P.","year":"1987","unstructured":"Scott P. Pearce E. Natovitz P. Sher A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.J. Immunol.1391987221227","journal-title":"J. Immunol."},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.4049\/jimmunol.139.9.3118","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract","volume":"139","author":"Scott P.","year":"1987","unstructured":"Scott P. Pearce E. Natovitz P. Sher A. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract.J. Immunol.139198731183125","journal-title":"J. Immunol."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01383.x"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3559-3566.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","unstructured":"Stone K. L. Williams K. R. Enzymatic digestion of proteins and HPLC peptide isolation.A practical guide to protein and peptide purification for microsequencing2nd ed.MatsudarraP.1993Academic PressNew York N.Y","DOI":"10.1016\/B978-0-08-092461-8.50009-5"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)86917-4"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(80)90227-1"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.107.9.2471"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang D. M.","year":"1990","unstructured":"Yang D. M. Fairweather N. Button L. L. McMaster W. R. Kahl L. P. Liew F. Y. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.J. Immunol.145199022812285","journal-title":"J. Immunol."},{"key":"e_1_3_2_60_2","first-page":"3","article-title":"Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major","volume":"72","author":"Yang D. M.","year":"1991","unstructured":"Yang D. M. Rogers M. V. Liew F. Y. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.Immunology72199139","journal-title":"Immunology"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.11.6776-6784.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.11.6776-6784.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:45:30Z","timestamp":1682264730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.11.6776-6784.2001"}},"subtitle":[],"editor":[{"given":"J. M.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1128\/IAI.69.11.6776-6784.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.11.6776-6784.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"2000-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-07-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}